Physician profile
Cheri O Vachtsevanos
NPI 1609844067
$5,468.28
in general payments reported to CMS, 2019-2025
39 companies · $572 in 2025
The $572 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $691 · 2021: $1,220 · 2022: $933 · 2023: $613 · 2024: $704 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876 · Entertainment: $13.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.33 |
| Entertainment | $13.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $856.88 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $564.86 | 2019-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $466.35 | 2020-2024 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $443.72 | 2019-2025 | Jardiance |
| Pfizer INC. | $431.68 | 2019-2025 | |
| Amarin Pharma, INC. | $305.68 | 2020-2022 | |
| Abbvie INC. | $303.77 | 2020-2025 | Vraylar, Synthroid, Ubrelvy |
| Novo Nordisk INC | $264.48 | 2019-2025 | Wegovy, Ozempic |
| Vanda Pharmaceuticals INC. | $256.23 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $224.55 | 2020-2025 | Gardasil 9, Dificid, Capvaxive |
| Janssen Pharmaceuticals, INC | $158.66 | 2020-2024 | Spravato |
| Abbott Laboratories | $140.89 | 2021-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $133.09 | 2021-2023 | |
| Catalyst Orthoscience | $111.68 | 2019 | |
| Exact Sciences Corporation | $105.06 | 2023-2025 | Cologuard Collection Kit |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheri Vachtsevanos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.